Steroid‐resistant eosinophilic fasciitis successfully treated with addition of extracorporeal photopheresis

Eosinophilic fasciitis (EF) is an uncommon fibrosing disease of the fascia with characteristic cutaneous and hematologic manifestations. Although EF is most commonly treated with corticosteroids at the beginning, a considerable number of patients show an inadequate response and hence various therapeutic strategies have been tried, including extracorporeal photopheresis (ECP). We describe the case of a 66‐year‐old woman with steroid‐resistant EF that improved significantly after ECP was added to her treatment regimen. To date, only six cases of this therapeutic strategy have been reported in English literature.

[1]  M. Fujimoto,et al.  Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis , 2018, The Journal of dermatology.

[2]  M. Arthur,et al.  Eosinophilic fasciitis: Current concepts. , 2018, Clinics in dermatology.

[3]  D. Mazori,et al.  Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment , 2017, Current Rheumatology Reports.

[4]  J. Adamski,et al.  Extracorporeal photopheresis for the treatment of autoimmune diseases. , 2015, Transfusion and Apheresis Science.

[5]  Heidrun Andreu-Ullrich Miscellaneous indications for extracorporeal photochemotherapy (ECP). , 2014, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[6]  A. Pileri,et al.  Bosentan and Extracorporeal Photochemotherapy in Eosinophilic Fasciitis , 2014, The international journal of lower extremity wounds.

[7]  S. Gangemi,et al.  Eosinophilic fasciitis associated with autoimmune phenomena after bone marrow transplantation: report of two cases , 2006, Clinical Rheumatology.

[8]  C. Romano,et al.  Extracorporeal photochemotherapy in the treatment of eosinophilic fasciitis , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.